| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10962915 | Vaccine | 2015 | 10 Pages |
Abstract
Administration of a 3-dose regimen of 9vHPV vaccine to adolescent girls and young women 12-26 years of age who are prior qHPV vaccine recipients is highly immunogenic with respect to HPV types 31/33/45/52/58 and generally well tolerated.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Suzanne M. Garland, Tak-Hong Cheung, Shelly McNeill, Lone Kjeld Petersen, Josefina Romaguera, Jorge Vazquez-Narvaez, Oliver Bautista, Christine Shields, Scott Vuocolo, Alain Luxembourg,